BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33417954
Number of visits today
4714
Number of downloads
16607577
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Sharma J, Bhatti MT, Danesh-Meyer HV. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro-ophthalmic review. Clin Exp Ophthalmol 2021;49:186-202. [PMID: 33426799 DOI: 10.1111/ceo.13863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wingerchuk DM, Weinshenker BG, Mccormick D, Barron S, Simone L, Jarzylo L. Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder. JMCP 2022;28:S3-S27. [DOI: 10.18553/jmcp.2022.28.12-a.s1] [Reference Citation Analysis]
2 Mewes D, Kuchling J, Schindler P, Khalil AAA, Jarius S, Paul F, Chien C. Diagnostik der Neuromyelitis-optica-Spektrum-Erkrankung (NMOSD) und der MOG-Antikörper-assoziierten Erkrankung (MOGAD). Klin Monbl Augenheilkd 2022;239:1315-1324. [DOI: 10.1055/a-1918-1824] [Reference Citation Analysis]
3 Foo R, Yau C, Singhal S, Tow S, Loo JL, Tan K, Milea D. Optic Neuritis in the Era of NMOSD and MOGAD: A Survey of Practice Patterns in Singapore. Asia Pac J Ophthalmol (Phila) 2022;11:184-95. [PMID: 35533337 DOI: 10.1097/APO.0000000000000513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang S, Qiao S, Li H, Zhang R, Wang M, Han T, Liu X, Wang Y. Risk Factors and Nomogram for Predicting Relapse Risk in Pediatric Neuromyelitis Optica Spectrum Disorders. Front Immunol 2022;13:765839. [DOI: 10.3389/fimmu.2022.765839] [Reference Citation Analysis]
5 Huang T, Chu Y. What's new in neuromyelitis optica spectrum disorder treatment? Taiwan J Ophthalmol 2022;0:0. [DOI: 10.4103/2211-5056.355329] [Reference Citation Analysis]
6 Huang T, Chu Y. What's new in neuromyelitis optica spectrum disorder treatment? Taiwan J Ophthalmol 2022;12:249. [DOI: 10.4103/2211-5056.355617] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345